Verthermia® provides Hyperthermic Extracorporeal Applied Tumor Therapy (HEATT®), a patented, whole-body hyperthermia cancer treatment to extend and enhance daily living in end-stage cancer patients.
For over thirty years, Verthermia® has worked to perfect the procedure of HEATT®. We prioritize safety by closely monitoring vitals during the entire cancer treatment procedure as we heat the body. With this heat, we target cancerous cells as blood circulates. HEATT® also results in a positive immune response, which enhances the body's defense system.
42° C has been scientifically identified as an optimal temperature because it can damage cancer cells while providing minimal harm to healthy cells.
We understand that choosing a cancer treatment can be overwhelming, but at Verthermia®, we are confident in the benefits of whole-body hyperthermia and its potential to improve your quality of life. We ensure that all patients understand the process before undergoing treatment to provide knowledge and peace of mind. Throughout this non-invasive procedure, the patient is also placed under anesthesia to ensure ultimate comfort.
To provide our patients with the best possible care, we offer a range of educational webinars and online resources about HEATT®. Our expert panelists and oncologists discuss topics such as the hyperthermia therapy process, all-encompassing trial results, patient success stories, and much more.
At Verthermia®, we are dedicated to providing patients with the absolute highest standard of care and safety. We follow strict guidelines so every patient who undergoes whole-body hyperthermia cancer treatment will do so safely to minimize complications. To be a candidate for HEATT®, a patient must meet certain criteria. Contact us today to further discuss your eligibility.
We understand that you may have some questions about our whole-body hyperthermia cancer treatment. We are here to answer your questions and provide information to make sure you feel comfortable with the process. We have compiled commonly asked questions to address your initial concerns.
Hyperthermia cancer treatment is a promising approach in the field of oncology, offering potential benefits for patients suffering from advanced-stage […]Read More For Overview
The Verthermia® team conducted an FDA Phase 1 clinical trial during 2014-2015, resulting in significant findings on the positive impact […]Read More For Overview
The image on the left shows the tumors at the beginning of the study. The image on the right shows […]Read More For Overview